首页    期刊浏览 2024年12月03日 星期二
登录注册

文章基本信息

  • 标题:Design and Molecular dynamic Investigations of 7,8-Dihydroxyflavone Derivatives as Potential Neuroprotective Agents Against Alpha-synuclein
  • 本地全文:下载
  • 作者:Thangavel Mohankumar ; Vivek Chandramohan ; Haralur Shankaraiah Lalithamba
  • 期刊名称:Scientific Reports
  • 电子版ISSN:2045-2322
  • 出版年度:2020
  • 卷号:10
  • 期号:1
  • 页码:1-10
  • DOI:10.1038/s41598-020-57417-9
  • 出版社:Springer Nature
  • 摘要:Abstract Parkinson’s disease (PD) is the second most common neurodegenerative disorder caused due to loss of dopaminergic neurons in substantia nigra pars compacta, which occurs the presence of Lewy bodies made up of Alpha-synuclein (ASN) aggregation resulting in neuronal death. This study aims to identify potent 7,8-Dihydroxyflavone (DHF) derivatives to inhibit the ASN aggregation from in silico analysis. Molecular docking study reveals that carbamic ester derivatives of DHF [DHF-BAHPC ( 8q ), DHF-BAHPEC ( 8s ), DHF-BAHEC ( 8p ), DHF-BDOPC ( 8c ), DHF-BAPEC ( 8n ) and DHF-BAMC ( 8h )] have good binding affinity towards ASN, when compared with DHF and L-DOPA; their docking score values are −16.3120, −16.1875, −15.2223, −14.3118, −14.2893, –14.2810, −14.0383, and −9.1560 kcal/mol respectively. The in silico pharmacological evaluation shows that these molecules exhibit the drug-likeness and ADMET properties. Molecular dynamics simulation confirms the stability of the molecules with ASN. The intermolecular interaction analyzed under the dynamic condition, allows to identify the candidate which potentially inhibits ASN aggregation. Hence, we propose that DHF derivatives are the potential lead drug molecules and preclinical studies are needed to confirm the promising therapeutic ability against PD.
国家哲学社会科学文献中心版权所有